These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 30988206)

  • 1. Functional characterization of 3D protein structures informed by human genetic diversity.
    Hicks M; Bartha I; di Iulio J; Venter JC; Telenti A
    Proc Natl Acad Sci U S A; 2019 Apr; 116(18):8960-8965. PubMed ID: 30988206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A framework for exhaustively mapping functional missense variants.
    Weile J; Sun S; Cote AG; Knapp J; Verby M; Mellor JC; Wu Y; Pons C; Wong C; van Lieshout N; Yang F; Tasan M; Tan G; Yang S; Fowler DM; Nussbaum R; Bloom JD; Vidal M; Hill DE; Aloy P; Roth FP
    Mol Syst Biol; 2017 Dec; 13(12):957. PubMed ID: 29269382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive characterization of amino acid positions in protein structures reveals molecular effect of missense variants.
    Iqbal S; Pérez-Palma E; Jespersen JB; May P; Hoksza D; Heyne HO; Ahmed SS; Rifat ZT; Rahman MS; Lage K; Palotie A; Cottrell JR; Wagner FF; Daly MJ; Campbell AJ; Lal D
    Proc Natl Acad Sci U S A; 2020 Nov; 117(45):28201-28211. PubMed ID: 33106425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Domain alternation and active site remodeling are conserved structural features of ubiquitin E1.
    Lv Z; Yuan L; Atkison JH; Aldana-Masangkay G; Chen Y; Olsen SK
    J Biol Chem; 2017 Jul; 292(29):12089-12099. PubMed ID: 28572513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The 3D mutational constraint on amino acid sites in the human proteome.
    Li B; Roden DM; Capra JA
    Nat Commun; 2022 Jun; 13(1):3273. PubMed ID: 35672414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of protein-coding genetic variation in 60,706 humans.
    Lek M; Karczewski KJ; Minikel EV; Samocha KE; Banks E; Fennell T; O'Donnell-Luria AH; Ware JS; Hill AJ; Cummings BB; Tukiainen T; Birnbaum DP; Kosmicki JA; Duncan LE; Estrada K; Zhao F; Zou J; Pierce-Hoffman E; Berghout J; Cooper DN; Deflaux N; DePristo M; Do R; Flannick J; Fromer M; Gauthier L; Goldstein J; Gupta N; Howrigan D; Kiezun A; Kurki MI; Moonshine AL; Natarajan P; Orozco L; Peloso GM; Poplin R; Rivas MA; Ruano-Rubio V; Rose SA; Ruderfer DM; Shakir K; Stenson PD; Stevens C; Thomas BP; Tiao G; Tusie-Luna MT; Weisburd B; Won HH; Yu D; Altshuler DM; Ardissino D; Boehnke M; Danesh J; Donnelly S; Elosua R; Florez JC; Gabriel SB; Getz G; Glatt SJ; Hultman CM; Kathiresan S; Laakso M; McCarroll S; McCarthy MI; McGovern D; McPherson R; Neale BM; Palotie A; Purcell SM; Saleheen D; Scharf JM; Sklar P; Sullivan PF; Tuomilehto J; Tsuang MT; Watkins HC; Wilson JG; Daly MJ; MacArthur DG;
    Nature; 2016 Aug; 536(7616):285-91. PubMed ID: 27535533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biophysical simulations and structure-based modeling of residue interaction networks in the tumor suppressor proteins reveal functional role of cancer mutation hotspots in molecular communication.
    Verkhivker GM
    Biochim Biophys Acta Gen Subj; 2019 Jan; 1863(1):210-225. PubMed ID: 30339916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutation effects predicted from sequence co-variation.
    Hopf TA; Ingraham JB; Poelwijk FJ; Schärfe CP; Springer M; Sander C; Marks DS
    Nat Biotechnol; 2017 Feb; 35(2):128-135. PubMed ID: 28092658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spectrum and Prevalence of CALM1-, CALM2-, and CALM3-Encoded Calmodulin Variants in Long QT Syndrome and Functional Characterization of a Novel Long QT Syndrome-Associated Calmodulin Missense Variant, E141G.
    Boczek NJ; Gomez-Hurtado N; Ye D; Calvert ML; Tester DJ; Kryshtal D; Hwang HS; Johnson CN; Chazin WJ; Loporcaro CG; Shah M; Papez AL; Lau YR; Kanter R; Knollmann BC; Ackerman MJ
    Circ Cardiovasc Genet; 2016 Apr; 9(2):136-146. PubMed ID: 26969752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of an N-terminal site of Ubc9 in SUMO-1, -2, and -3 binding and conjugation.
    Tatham MH; Kim S; Yu B; Jaffray E; Song J; Zheng J; Rodriguez MS; Hay RT; Chen Y
    Biochemistry; 2003 Aug; 42(33):9959-69. PubMed ID: 12924945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Integrated Deep-Mutational-Scanning Approach Provides Clinical Insights on PTEN Genotype-Phenotype Relationships.
    Mighell TL; Thacker S; Fombonne E; Eng C; O'Roak BJ
    Am J Hum Genet; 2020 Jun; 106(6):818-829. PubMed ID: 32442409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small-molecule binding sites to explore protein-protein interactions in the cancer proteome.
    Xu D; Jalal SI; Sledge GW; Meroueh SO
    Mol Biosyst; 2016 Oct; 12(10):3067-87. PubMed ID: 27452673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insights into Disease-Associated Mutations in the Human Proteome through Protein Structural Analysis.
    Gao M; Zhou H; Skolnick J
    Structure; 2015 Jul; 23(7):1362-9. PubMed ID: 26027735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural Studies of ERK2 Protein Complexes.
    Weijman JF; Riedl SJ; Mace PD
    Methods Mol Biol; 2017; 1487():53-63. PubMed ID: 27924558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structures of the SUMO E1 provide mechanistic insights into SUMO activation and E2 recruitment to E1.
    Lois LM; Lima CD
    EMBO J; 2005 Feb; 24(3):439-51. PubMed ID: 15660128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can Predicted Protein 3D Structures Provide Reliable Insights into whether Missense Variants Are Disease Associated?
    Ittisoponpisan S; Islam SA; Khanna T; Alhuzimi E; David A; Sternberg MJE
    J Mol Biol; 2019 May; 431(11):2197-2212. PubMed ID: 30995449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The SuMo server: 3D search for protein functional sites.
    Jambon M; Andrieu O; Combet C; Deléage G; Delfaud F; Geourjon C
    Bioinformatics; 2005 Oct; 21(20):3929-30. PubMed ID: 16141250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel peroxisome proliferator-activated receptor gamma mutation in a family with familial partial lipodystrophy type 3.
    Miehle K; Porrmann J; Mitter D; Stumvoll M; Glaser C; Fasshauer M; Hoffmann K
    Clin Endocrinol (Oxf); 2016 Jan; 84(1):141-8. PubMed ID: 26119484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A bipartite mechanism for ERK2 recognition by its cognate regulators and substrates.
    Zhang J; Zhou B; Zheng CF; Zhang ZY
    J Biol Chem; 2003 Aug; 278(32):29901-12. PubMed ID: 12754209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of SUMO-1 modified proteins in E. coli: towards understanding the biochemistry/structural biology of the SUMO-1 pathway.
    Uchimura Y; Nakao M; Saitoh H
    FEBS Lett; 2004 Apr; 564(1-2):85-90. PubMed ID: 15094046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.